Nephrotic syndrome – Diagnostics – Overview of Information and Clinical Research

Understanding how nephrotic syndrome is identified can help you know when to seek medical attention and what to expect during the diagnostic process. Early detection through the right tests allows doctors to understand the underlying cause and plan appropriate treatment to protect your kidneys.

Who Should Undergo Diagnostics and When to Seek Testing

You should consider seeing a doctor if you notice certain warning signs that might suggest nephrotic syndrome. The most obvious symptom is swelling, particularly around your eyes when you wake up in the morning, or in your ankles and legs throughout the day. This swelling happens because your kidneys are losing protein, which affects how your body manages fluid.^[1]

Another important sign is foamy or frothy urine. This occurs because large amounts of protein are being released into your urine, creating bubbles that don’t quickly disappear. If you notice this change along with unexplained weight gain from fluid retention, it’s time to schedule an appointment with your doctor.^[2]

Adults should seek diagnostics if they experience these symptoms along with fatigue and loss of appetite. Children, especially those between ages 1 and 6, are more likely to develop nephrotic syndrome, and parents should watch for facial puffiness that seems different from normal morning sleepiness or that spreads to other parts of the body.^[3]

People with certain risk factors should be particularly alert. If you have diabetes, lupus, or a family history of kidney disease, you’re at higher risk for developing nephrotic syndrome. Those who have allergies or who have recently had an upper respiratory tract infection should also pay attention to any unusual swelling or changes in urination.^[2]

⚠️ Important

Do not wait if your swelling is severe or if you develop abdominal pain, feel generally unwell, or notice significant changes in how much urine you produce. These could indicate complications that need immediate attention. Early diagnosis helps prevent damage to your kidneys and reduces the risk of serious complications like blood clots or infections.

Classic Diagnostic Methods Used to Identify Nephrotic Syndrome

Diagnosing nephrotic syndrome starts with simple tests that can quickly reveal whether your kidneys are releasing too much protein. The most straightforward initial test is urinalysis, where a small sample of your urine is tested using a special dipstick. When the stick is dipped into your urine, it changes color if large amounts of protein are present. This quick test can be done in your doctor’s office and provides immediate clues about kidney function.^[8]

If the dipstick test shows protein in your urine, your doctor will likely ask you to collect a 24-hour urine sample. This means you’ll save all your urine over a full day in a special container. Laboratory technicians then measure exactly how much protein you’re losing. In nephrotic syndrome, you lose more than 3 grams of protein per day, which is about 20 times the normal amount. However, because collecting urine for 24 hours can be inconvenient, many doctors now use a simpler alternative called a spot urine protein-to-creatinine ratio. This test uses just one urine sample instead of a full day’s collection and can give equally reliable results.^[9]^[11]

Blood tests are equally important in diagnosing nephrotic syndrome. A blood sample will be analyzed to measure the level of albumin, which is the main protein in your blood. People with nephrotic syndrome have low blood albumin levels, typically below 3.5 grams per deciliter, because this protein is being lost through the urine. The same blood test usually checks your overall blood protein level, which is also typically decreased.^[8]

Your doctor will also order blood tests to assess your kidney function more broadly. These include measuring creatinine and urea nitrogen levels in your blood. When these substances build up in your blood instead of being filtered out by your kidneys, it suggests your kidneys aren’t working as well as they should. These tests help doctors understand how severely your kidneys are affected.^[8]

Blood tests will also reveal if you have hyperlipidemia, meaning high levels of cholesterol and triglycerides (types of fat) in your blood. This happens because when your body loses protein, your liver tries to compensate by making more protein, but it also produces extra cholesterol and fats in the process. These high fat levels are a characteristic feature of nephrotic syndrome.^[3]

In some cases, particularly when the initial treatment doesn’t work or when doctors suspect certain underlying causes, a kidney biopsy may be recommended. During this procedure, a doctor inserts a thin needle through your skin and into your kidney to remove a tiny sample of kidney tissue. This tissue is then examined under a microscope to identify the specific disease causing the nephrotic syndrome. For example, it can reveal whether you have minimal change disease, focal segmental glomerulosclerosis, or membranous nephropathy. Each of these conditions may require different treatment approaches.^[8]

A kidney biopsy is most useful when doctors need to determine the exact type of kidney disease you have, especially in adults. In children, doctors often begin treatment without a biopsy because the most common cause in children is minimal change disease, which responds well to standard treatment. However, if a child doesn’t respond to initial treatment, a biopsy may then be performed to guide further decisions.^[14]

Your doctor will also want to identify any underlying conditions that might be causing secondary nephrotic syndrome. This means they’ll look for signs of diabetes by checking your blood sugar levels, or lupus by testing for specific antibodies in your blood. They’ll review your medications to see if any drugs you’re taking could be affecting your kidneys. They may also ask about recent infections, particularly strep throat or other upper respiratory infections, which can sometimes trigger kidney problems.^[3]^[11]

The diagnostic process helps distinguish nephrotic syndrome from other conditions that might cause similar symptoms. For instance, heart failure and severe liver disease can also cause swelling, but the pattern of protein loss and blood test results are different. Nephritic syndrome is another kidney condition that doctors need to rule out. While both conditions affect the kidneys, nephritic syndrome typically involves red blood cells in the urine and signs of kidney inflammation, whereas nephrotic syndrome is characterized primarily by heavy protein loss without blood cells in the urine.^[5]

Diagnostics for Clinical Trial Qualification

When doctors are considering whether a patient might be eligible for a clinical trial studying new treatments for nephrotic syndrome, they use specific standardized tests. These tests ensure that all patients enrolled in the study have comparable disease characteristics, which makes the research results more reliable and meaningful.

The primary requirement for most nephrotic syndrome clinical trials is confirmation of nephrotic-range proteinuria. This is defined as losing 3 grams or more of protein per 24 hours in urine, or showing a protein-to-creatinine ratio of 2 grams of protein per gram of creatinine in a spot urine sample. This threshold is universally accepted in research settings because it clearly defines the severity of protein loss that characterizes nephrotic syndrome.^[3]

Blood tests confirming hypoalbuminemia are also standard criteria. Most clinical trials require that blood albumin levels be below 3 grams per deciliter (or 30 grams per liter), demonstrating that the protein loss is severe enough to lower blood protein levels significantly. This measurement helps researchers ensure they’re studying patients with true nephrotic syndrome rather than milder forms of protein loss.^[3]

Clinical trials often require a kidney biopsy to have been performed before enrollment. This biopsy identifies the specific type of kidney disease causing the nephrotic syndrome, such as focal segmental glomerulosclerosis, membranous nephropathy, or minimal change disease. Many trials focus on one specific type of kidney disease, so confirming the diagnosis through biopsy is essential. The biopsy report provides detailed information about the microscopic changes in the kidney tissue, which helps researchers understand exactly what disease process they’re studying.^[11]

Kidney function tests, particularly measuring estimated glomerular filtration rate (eGFR), are crucial for trial qualification. The eGFR indicates how well your kidneys are filtering waste from your blood. Different trials have different eGFR requirements. Some trials may only accept patients whose kidneys are still functioning reasonably well, while others might specifically study patients with reduced kidney function. This measurement is calculated from your blood creatinine level, age, sex, and sometimes race.^[9]

Researchers also use blood tests to check for secondary causes of nephrotic syndrome that might exclude someone from a trial. For example, they’ll test for diabetes with blood glucose or hemoglobin A1c measurements, and for lupus with antibody tests. Most trials studying primary nephrotic syndrome specifically exclude patients whose condition is caused by diabetes or other systemic diseases, because these patients may respond differently to treatment.^[11]

For trials testing immunosuppressive medications, baseline tests of immune function and blood cell counts are required. These include complete blood counts to measure white blood cells, red blood cells, and platelets. Doctors need to ensure patients can safely receive immune-suppressing drugs without putting them at excessive risk for infections or bleeding problems. Liver function tests are also typically required, as many medications used in nephrotic syndrome are processed by the liver.^[13]

Some clinical trials measure additional markers that aren’t part of routine diagnosis but help researchers better understand how treatments work. These might include tests for specific proteins lost in urine beyond albumin, or measurements of blood cholesterol and triglyceride levels. Researchers may also collect urine samples to store for future analysis of biomarkers that could predict treatment response.^[11]

Prognosis and Survival Rate

Prognosis

The outlook for people with nephrotic syndrome varies considerably depending on several important factors. The underlying cause of the syndrome is the most significant factor determining long-term outcomes. In children, the prognosis is generally very good, especially when the cause is minimal change disease, which is the most common type in young patients. Most children respond well to steroid medications, and while they may experience periods when symptoms return (relapses), these relapses typically become less frequent as the child grows older and often stop completely by late adolescence.^[14]

Adults tend to have more variable outcomes. Those with minimal change disease usually have an excellent prognosis similar to children. However, adults more commonly have other types of kidney disease causing their nephrotic syndrome, such as focal segmental glomerulosclerosis or membranous nephropathy, which may be more challenging to treat. Some patients achieve complete remission where all symptoms disappear, while others may have persistent low-level protein loss or experience repeated relapses over many years.^[11]

Without proper treatment, nephrotic syndrome is serious and can affect life expectancy due to complications like blood clots, infections, and progressive kidney damage. However, with appropriate medical care, many people can live essentially normal lives. The key to a better prognosis is early diagnosis, proper treatment, and careful monitoring to prevent complications.^[2]

Some patients may eventually develop chronic kidney disease or even kidney failure requiring dialysis or transplantation, particularly if they have types of nephrotic syndrome that don’t respond well to treatment. However, this represents a minority of cases. Regular follow-up with a kidney specialist (nephrologist) helps identify any worsening kidney function early so that interventions can be adjusted.^[22]

For patients whose nephrotic syndrome goes into remission, the quality of life can be excellent. Many are able to work, study, engage in physical activities, and lead full lives. Women with nephrotic syndrome can become pregnant and deliver healthy babies, although pregnancy requires careful monitoring by both a nephrologist and obstetrician due to increased risks of complications. Most forms of nephrotic syndrome are not hereditary and cannot be passed to children.^[22]

Survival rate

Specific survival statistics for nephrotic syndrome as a whole are not well established in the medical literature because outcomes vary so dramatically based on the underlying cause, patient age, and response to treatment. Nephrotic syndrome itself is not typically measured by survival rates in the same way that cancers are, because it is a syndrome (collection of symptoms) rather than a single disease.

What is known is that children with the most common form, minimal change disease, have survival rates approaching normal population levels when properly treated. The condition rarely progresses to kidney failure in children, and most achieve long-term remission.^[14]

In adults, survival depends heavily on the specific kidney disease causing the nephrotic syndrome and whether kidney function deteriorates over time. Patients who progress to end-stage kidney failure requiring dialysis have survival rates similar to other dialysis patients. However, many patients with nephrotic syndrome never reach this stage, especially with modern treatments. Kidney transplantation can be an excellent option for those who do develop kidney failure, though some forms of nephrotic syndrome can occasionally recur in the transplanted kidney.^[22]

The relatively rare occurrence of nephrotic syndrome (about 3 in 100,000 adults per year and 1 in 50,000 children per year) means that large-scale survival studies are challenging to conduct. Individual prognosis should always be discussed with your nephrologist, who can provide information specific to your type of nephrotic syndrome and personal health situation.^[2]

#1 Clinical Trials Search in Europe